Skip to content

Study · Measured the body's own peptide · 2021

1 result

Inflammasome-mediated Inflammation by Malassezia in human keratinocytes: A comparative analysis with different strains.

Park HR, Oh JH, Lee YJ, Park SH, Lee YW, Lee S, Kang H, Kim JE

Mycoses2 Dec 2020Cited by 30 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Mechanism

    In human keratinocytes, three Malassezia species variably induced expression of the body's own LL‑37, together with thymic stromal lymphopoietin and beta-defensin 2.

    In plain wordsIn human skin cells, different Malassezia fungi raised the cells' own LL‑37 to different degrees.

    Peptide
    LL-37
    Outcome
    MixedLL-37 induction by Malassezia species
    Study

    humann: not reported in source

    Human keratinocytes
    Outcome group
    Immune response · Skin and wound

    Source sentences

    Summary
    Malassezia species variably induced thymic stromal lymphopoietin, β-defensin 2, and LL-37.
    1 context sentence
    Summary · context
    We compared the different activation patterns of inflammasomes and the expression of pro-inflammatory cytokines and antimicrobial peptides by three different Malassezia species-M. restricta, M. globosa and M. sympodialis-in human keratinocytes.

    This result measures the body's own LL-37. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    11 Oct 2026, 00:50 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 02:57 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.